Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS)
Forecast
Centers for Disease Control and Prevention - ERA plans to offer grants of up to $500,000 to any type of organization. It expects to make about 3 awards worth $4.5 million in total. It is a forecast: the notice is expected around October 1, 2026, with applications due around December 1, 2026.
From the official notice on Grants.gov, last changed July 8, 2026. Checked October 31, 2026.
- Award ceiling$500,000
- Award floornot stated
- Expected awards3
- Total funding$4.5 million
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Forecast posted | July 8, 2026 |
|---|---|
| Expected posting | October 1, 2026 |
| Expected deadline | December 1, 2026 |
| Expected award date | August 29, 2027 |
Add the deadline to your calendar
Who can apply
This opportunity is open to any type of organization.
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Additional Eligibility Information to be included in the NOFO.
Is this a realistic fit?
- No cost sharing or match is required.
What the grant funds
CDC/ATSDR is inviting research proposals to study risk factors for Amyotrophic Lateral Sclerosis (ALS). Studies on military service, contact sports, traumatic brain injury, neuroinflammation, and infections agents and exposures are encouraged. Funding will be for four funding options: Option A - Support research with strong existing evidence such as studies on known environmental or genetic risk factors, research that improves past studies with better data, or investigations linking risk factors to ALS diagnosis and treatment; Option B - Support new and exploratory research on ALS risk factors such as studies on risk factors with little existing evidence or research using innovative methods; Option C - Understand ALS risk in affected populations, such as studies involving military veterans or investigations of ALS risk factors impacting this population; Option D - Analyze biological samples from the Guamanian ALS cluster such as investigation of disease mechanisms and environmental factors, exposure routes, genetic studies and biomarkers and how this could lead to mitigation therapeutics, diagnostics or prevention.
How to apply
- Read the full notice and attachments on Grants.gov. The notice is the official source for deadlines and requirements.
- Make sure your organization has an active SAM.gov registration and Unique Entity ID; registration can take several weeks.
- Register on Grants.gov and submit through Workspace before the deadline and time given in the notice. Our application guide walks through each step.
Questions go to Dr. Candis Hunter, ncipc_erpo@cdc.gov, 770-488-1347.
Questions people ask
Who can apply for Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS)?
Centers for Disease Control and Prevention - ERA accepts applications from any type of organization. The notice adds further conditions, so read its eligibility section.
What is the deadline for Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS)?
Expected deadline December 1, 2026. Confirm the date and time in the official notice on Grants.gov.
How much funding is available?
Awards of up to $500,000 each. About $4.5 million in total across about 3 awards.
Similar open grants
- Continuation of the Collaborative Islet Transplantation Registry (U01 Clinical Trial Not allowed)
- BRAIN Initiative Cell Atlas Network (BICAN): Coordinating Unit for Biostatistics, Informatics, and Engagement (CUBIE)
- Centers without Walls for mechanisms of neurodegeneration in Alzheimer’s disease-related dementias (ADRD)
- Expanding the Therapeutic Pipeline for Treating and Preventing Alzheimer's Disease and Related Dementias: Preclinical Validation and Drug Discovery for Novel Candidate Targets (U01 Clinical Trial Not Allowed)
- Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE, RP1 Clinical Trial Not Allowed)
- Exposomic Contributions to ADRD Pathology and Resilience